Center-Authored Papers

Filters: Author is Paquette, Ronald L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Thalidomide
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Prospective Studies
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Primary Myelofibrosis
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Prednisone
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Middle Aged
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Male
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Immunologic Factors
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Humans
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Hematinics
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Glucocorticoids
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Female
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Double-Blind Method
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Clinical Research Division
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Anemia
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Aged, 80 and over
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Aged
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
Adult
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract
2009
Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ et al..  2009.  Pomalidomide is active in the treatment of anemia associated with myelofibrosis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(27):4563-9. Abstract